CluePoints launched Intelligent Query Detection (IQD), Medical & Safety Review (MSR), and Intelligent Medical Coding (IMC) as AI-led capabilities co-innovated with a top-10 pharmaceutical company.
Published
Signal category
Products & Services
Quote
“Yesterday marked an exciting milestone for CluePoints with the launch of Intelligent Query Detection (IQD), Medical & Safety Review (MSR) and Intelligent Medical Coding (IMC).”
— Catherine Ditzler|CluePoints team
Company
CluePoints
AI-Powered Risk-Based Quality Management (RBQM) & Data Quality Oversight Solutions
- Industry
- Software Development
- Location
- Avenue Albert Einstein 2A, BE
- Company size
- 312 employees
CluePoints is the premier provider of RBQM and data quality oversight software. We’re leveraging the potential of AI using advanced statistics and ML to determine the quality, accuracy, and integrity of clinical trial data both during and after the study. Aligned with guidance from the FDA, EMA, ICH, and MHRA, CluePoints supports central and on-site monitoring, medical review, and quality risk management to drive a holistic risk-based strategy. Coupled with thought leadership and consulting expertise to aid risk assessment and solution implementation, the result is positive clinical development outcomes, increased operational efficiency, lower costs, and reduced regulatory submission risk as part of the industry paradigm shift to RBQM. To learn more about CluePoints, visit CluePoints.com.
Founded 2012